Question 1

Target Groups for Screening

Accepted Answer

Individuals with known genetic mutations (e.g., BRCA2, CDKN2A, or STK11). People with two or more first-degree relatives diagnosed with pancreatic cancer. Individuals with Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome. Patients with hereditary pancreatitis.

Question 2

Importance of Early Detection

Accepted Answer

Significantly increases the chances of successful treatment by finding tumors early. Enables monitoring of precancerous cysts before they progress to cancer. Provides peace of mind for individuals with high genetic predisposition. Utilizes high-resolution imaging that surpasses standard physical exams.

Question 3

What Does the Program Include?

Accepted Answer

Magnetic Resonance Cholangiopancreatography (MRI/MRCP) for detailed ductal imaging. Endoscopic Ultrasound (EUS) for high-definition visualization of pancreatic tissue. Comprehensive clinical evaluation and personalized annual surveillance planning.

High-Risk Pancreatic Cancer Screening